Global Biobanks Market Size, Status and Forecast 2019-2025

A biobank can be defined as an organized and programed storage of biological materials and corresponding data that can be used in healthcare research. The biological samples vital for medical innovation include tissue, body fluids (such as serum, blood, urine, or fluids from punctures), related derivatives (RNA, DNA, or proteins), and cells.

As biobanks help in providing personalized medications and minimizing drug side effects, thereby improving the overall health of patients suffering from various diseases, the demand for biobanks will augment worldwide. Some of the key factors driving the market for biobanks are advancement in drug discovery, rising prevalence of chronic disorders such as cancer, respiratory disorders, and cardiovascular diseases, increasing healthcare expenditure, and several government initiatives supporting the development of biobanks. Another growth driver of the global biobanks market is the gradual propagation of awareness about biobanks and their significance.
In 2018, the global Biobanks market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Biobanks status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biobanks development in United States, Europe and China.

The key players covered in this study
Thermo Fisher Scientific (US)
Tecan Group (Switzerland)
Qiagen (Germany)
Hamilton (US)
Brooks Automation (US)
TTP Labtech (UK)
Promega (US)
Worthington Industries (US)
Chart Industries (US)
Becton Dickinson (US)
Merck (Germany)
Micronic (Netherlands)
LVL Technologies (Germany)
Panasonic Healthcare (Japan)
Greiner Bio One (Greiner Holding AG, Austria)
Biokryo (Germany)
Biobank (Norway)
Biorep Technologies (US)
Cell & Co Bioservices (France)
RUCDR infinite biologics (US)
Modul-Bio (France)
CSols (UK)
Ziath (UK)
LabVantage Solutions (US)

Market segment by Type, the product can be split into
Blood Products
Human Tissues
Nucleic Acids
Cell Lines
Biological Fluids
Human Waste Products

Market segment by Application, split into
Regenerative Medicine
Life Science Research
Clinical Research

Market segment by Regions/Countries, this report covers
United States
Southeast Asia
Central & South America

The study objectives of this report are:
To analyze global Biobanks status, future forecast, growth opportunity, key market and key players.
To present the Biobanks development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Biobanks are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Biobanks Market Size Growth Rate by Type (2014-2025)
1.4.2 Blood Products
1.4.3 Human Tissues
1.4.4 Nucleic Acids
1.4.5 Cell Lines
1.4.6 Biological Fluids
1.4.7 Human Waste Products
1.5 Market by Application
1.5.1 Global Biobanks Market Share by Application (2014-2025)
1.5.2 Regenerative Medicine
1.5.3 Life Science Research
1.5.4 Clinical Research
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Biobanks Market Size
2.2 Biobanks Growth Trends by Regions
2.2.1 Biobanks Market Size by Regions (2014-2025)
2.2.2 Biobanks Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Biobanks Market Size by Manufacturers
3.1.1 Global Biobanks Revenue by Manufacturers (2014-2019)
3.1.2 Global Biobanks Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Biobanks Market Concentration Ratio (CR5 and HHI)
3.2 Biobanks Key Players Head office and Area Served
3.3 Key Players Biobanks Product/Solution/Service
3.4 Date of Enter into Biobanks Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Biobanks Market Size by Type (2014-2019)
4.2 Global Biobanks Market Size by Application (2014-2019)

5 United States
5.1 United States Biobanks Market Size (2014-2019)
5.2 Biobanks Key Players in United States
5.3 United States Biobanks Market Size by Type
5.4 United States Biobanks Market Size by Application

6 Europe
6.1 Europe Biobanks Market Size (2014-2019)
6.2 Biobanks Key Players in Europe
6.3 Europe Biobanks Market Size by Type
6.4 Europe Biobanks Market Size by Application

7 China
7.1 China Biobanks Market Size (2014-2019)
7.2 Biobanks Key Players in China
7.3 China Biobanks Market Size by Type
7.4 China Biobanks Market Size by Application

8 Japan
8.1 Japan Biobanks Market Size (2014-2019)
8.2 Biobanks Key Players in Japan
8.3 Japan Biobanks Market Size by Type
8.4 Japan Biobanks Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Biobanks Market Size (2014-2019)
9.2 Biobanks Key Players in Southeast Asia
9.3 Southeast Asia Biobanks Market Size by Type
9.4 Southeast Asia Biobanks Market Size by Application

10 India
10.1 India Biobanks Market Size (2014-2019)
10.2 Biobanks Key Players in India
10.3 India Biobanks Market Size by Type
10.4 India Biobanks Market Size by Application

11 Central & South America
11.1 Central & South America Biobanks Market Size (2014-2019)
11.2 Biobanks Key Players in Central & South America
11.3 Central & South America Biobanks Market Size by Type
11.4 Central & South America Biobanks Market Size by Application

12 International Players Profiles
12.1 Thermo Fisher Scientific (US)
12.1.1 Thermo Fisher Scientific (US) Company Details
12.1.2 Company Description and Business Overview
12.1.3 Biobanks Introduction
12.1.4 Thermo Fisher Scientific (US) Revenue in Biobanks Business (2014-2019)
12.1.5 Thermo Fisher Scientific (US) Recent Development
12.2 Tecan Group (Switzerland)
12.2.1 Tecan Group (Switzerland) Company Details
12.2.2 Company Description and Business Overview
12.2.3 Biobanks Introduction
12.2.4 Tecan Group (Switzerland) Revenue in Biobanks Business (2014-2019)
12.2.5 Tecan Group (Switzerland) Recent Development
12.3 Qiagen (Germany)
12.3.1 Qiagen (Germany) Company Details
12.3.2 Company Description and Business Overview
12.3.3 Biobanks Introduction
12.3.4 Qiagen (Germany) Revenue in Biobanks Business (2014-2019)
12.3.5 Qiagen (Germany) Recent Development
12.4 Hamilton (US)
12.4.1 Hamilton (US) Company Details
12.4.2 Company Description and Business Overview
12.4.3 Biobanks Introduction
12.4.4 Hamilton (US) Revenue in Biobanks Business (2014-2019)
12.4.5 Hamilton (US) Recent Development
12.5 Brooks Automation (US)
12.5.1 Brooks Automation (US) Company Details
12.5.2 Company Description and Business Overview
12.5.3 Biobanks Introduction
12.5.4 Brooks Automation (US) Revenue in Biobanks Business (2014-2019)
12.5.5 Brooks Automation (US) Recent Development
12.6 TTP Labtech (UK)
12.6.1 TTP Labtech (UK) Company Details
12.6.2 Company Description and Business Overview
12.6.3 Biobanks Introduction
12.6.4 TTP Labtech (UK) Revenue in Biobanks Business (2014-2019)
12.6.5 TTP Labtech (UK) Recent Development
12.7 VWR (US)
12.7.1 VWR (US) Company Details
12.7.2 Company Description and Business Overview
12.7.3 Biobanks Introduction
12.7.4 VWR (US) Revenue in Biobanks Business (2014-2019)
12.7.5 VWR (US) Recent Development
12.8 Promega (US)
12.8.1 Promega (US) Company Details
12.8.2 Company Description and Business Overview
12.8.3 Biobanks Introduction
12.8.4 Promega (US) Revenue in Biobanks Business (2014-2019)
12.8.5 Promega (US) Recent Development
12.9 Worthington Industries (US)
12.9.1 Worthington Industries (US) Company Details
12.9.2 Company Description and Business Overview
12.9.3 Biobanks Introduction
12.9.4 Worthington Industries (US) Revenue in Biobanks Business (2014-2019)
12.9.5 Worthington Industries (US) Recent Development
12.10 Chart Industries (US)
12.10.1 Chart Industries (US) Company Details
12.10.2 Company Description and Business Overview
12.10.3 Biobanks Introduction
12.10.4 Chart Industries (US) Revenue in Biobanks Business (2014-2019)
12.10.5 Chart Industries (US) Recent Development
12.11 Becton Dickinson (US)
12.12 Merck (Germany)
12.13 Micronic (Netherlands)
12.14 LVL Technologies (Germany)
12.15 Panasonic Healthcare (Japan)
12.16 Greiner Bio One (Greiner Holding AG, Austria)
12.17 Biokryo (Germany)
12.18 Biobank (Norway)
12.19 Biorep Technologies (US)
12.20 Cell & Co Bioservices (France)
12.21 RUCDR infinite biologics (US)
12.22 Modul-Bio (France)
12.23 CSols (UK)
12.24 Ziath (UK)
12.25 LabVantage Solutions (US)

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach Research Programs/Design Market Size Estimation Market Breakdown and Data Triangulation
15.1.2 Data Source Secondary Sources Primary Sources
15.2 Disclaimer
15.3 Author Details

1.1 Methodology/Research Approach

Our research methodology implements a mix of primary as well as secondary research. Our projects are initiated with secondary research, where we refer to a variety of sources including trade databases; government published documents, investor presentations, company annual reports, white papers, and paid databases.

1.1.1 Research Programs/Design

1.1.2 Market Size Estimation

Post the initial data mining stage, we gather our findings and analyse them, filtering out relevant insights. These are evaluated across teams and by our in-house SMEs. Along with data mining, we also initiate the primary research phase in which we interact with companies operating within the market space.

To evaluate the wholeness of the market, we interact (via email or telephone) with players who are responsible in adding value to the final product. Additionally, we interact with related industries to understand the external factors that can drive/hamper a market. We also make it a point to evaluate various economic parameters, which typically, have an impact on the purchasing choices of individuals as well as companies.

Post these stages, data are cross-verified with the companies that operate in a market space. It is important for us to study these companies in detail, to understand their existing performance and future strategies which will define the market in the coming years.

All this data is collected and evaluated by our analysts. Post the preparation of the report and data analysis, the findings are presented to our in-house experts who then eliminate discrepancies (if any).

  • The key players in the industry and markets have been identified through extensive secondary research.
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
  • All percentage shares splits, and breakdowns have been determined using secondary sources and verified through primary sources.

1.2 Data Source

1.2.1 Secondary Sources

In the secondary research process, various secondary sources, such as D&B Hoovers, Bloomberg BusinessWeek, and Factiva, have been referred to, for identifying and collecting information for this study. Secondary sources included annual reports, press releases, and investor presentations of companies; whitepapers, certified publications, and articles by recognized authors; gold standard and silver standard websites; regulatory bodies; trade directories; and databases.

List of secondary sources include but are not limited to:

  • Academic Journals
  • Bloomberg
  • Company Annual Report
  • Hoovers Preliminary data mining

Raw market data is obtained and collated on a broad front. Data is continuously filtered to ensure that only validated and authenticated sources are considered. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. For comprehensive understanding of the market, it is essential to understand the complete value chain and in order to facilitate this; we collect data from raw material suppliers, distributors as well as buyers.

Technical issues and trends are obtained from surveys, technical symposia and trade journals. Technical data is also gathered from intellectual property perspective, focusing on white space and freedom of movement. Industry dynamics with respect to drivers, restraints, pricing trends are also gathered. As a result, the material developed contains a wide range of original data that is then further cross-validated and authenticated with published sources.

1.2.2 Primary Sources

This is the final step in estimating and forecasting for our reports. Exhaustive primary interviews are conducted, on face to face as well as over the phone to validate our findings and assumptions used to obtain them. Interviewees are approached from leading companies across the value chain including suppliers, technology providers, domain experts and buyers so as to ensure a holistic and unbiased picture of the market. These interviews are conducted across the globe, with language barriers overcome with the aid of local staff and interpreters. Primary interviews not only help in data validation, but also provide critical insights into the market, current business scenario and future expectations and enhance the quality of our reports. All our estimates and forecast are verified through exhaustive primary research with Key Industry Participants (KIPs) which typically include:

  • Market leading companies
  • Raw material suppliers
  • Product distributors
  • Buyers

The key objectives of primary research are as follows:

  • To validate our data in terms of accuracy and acceptability
  • To gain an insight in to the current market and future expectations

1.2.3 Statistical model

Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development and pricing trends is fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression and time series analysis. Market forecasting is performed via a combination of economic tools, technological analysis, and industry experience and domain expertise.

Econometric models are generally used for short-term forecasting, while technological market models are used for long-term forecasting. These are based on an amalgamation of technology landscape, regulatory frameworks, economic outlook and business principles. A bottom-up approach to market estimation is preferred, with key regional markets analyzed as separate entities and integration of data to obtain global estimates. This is critical for a deep understanding of the industry as well as ensuring minimal errors. Some of the parameters considered for forecasting include:

  • Market drivers and restrains, along with their current and expected impact
  • Raw material scenario and supply v/s price trends
  • Regulatory scenario and expected developments
  • Current capacity and expected capacity additions up to 2026

We assign weights to these parameters and quantify their market impact using weighted average analysis, to derive an expected market growth rate.

1.2.4 Data Triangulation

After arriving at the overall market size using the market size estimation processes as explained above, the market was split into several segments and sub segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub segment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying several factors and trends from both the demand and supply sides.

1.2.5 Report Objectives

  • To define, describe, and forecast the market by segmentations, and region
  • To provide detailed information about the major factors (drivers, restraints, opportunities, and challenges) influencing the growth of the market
  • To analyze the sub-segments with respect to individual growth trends, prospects, and contributions to the total market
  • To analyze opportunities in the market for stakeholders and provide the competitive landscape of the market
  • To forecast the revenues of the market segments with respect to the major regions, such as North America, Europe, Asia Pacific (APAC), and RoW
  • To profile the key players and comprehensively analyze their recent developments and positioning in the market
  • To analyze competitive developments, such as mergers and acquisitions, new product developments, and Research and Development (R&D) activities, in the market
Release date:September 26, 2019
Last updated:January 1, 1970
File Type:PDF
Category:Machinery & Equipment
Number Of Pages:100-150
Release date:September 26, 2019
Last updated:January 1, 1970
File Type:PDF
Category:Machinery & Equipment
Number Of Pages:100-150

Purchase Report


Download Category:

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why SMR?

Detailed Coverage

Detailed scope covering all the major segments in the market

Meticulous Data Validations

In line data validations to ensure data precision


Market recommendations supporting decision making processes

Analyst Support

Round the clock analyst support to resolve your queries

Free Customization

Up to 15% additional free customization to meet your specific requirements